The role of the putative virulence markers (cagA and vacA) of Helicobacter pylori in peptic ulcer disease

Saudi Medical Journal

Volumn 25, Issue 7, 2004, Pages 830-836

  Salih, Barik A ^a  

^a FATIH UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

CAGA PROTEIN; VACUOLATING TOXIN;

BACTERIAL STRAIN; BACTERIAL VIRULENCE; CARCINOGENESIS; DISEASE ASSOCIATION; DISEASE SEVERITY; HELICOBACTER PYLORI; HUMAN; MOLECULAR MECHANICS; OUTCOMES RESEARCH; PATHOGENESIS; PATHOGENICITY ISLAND; PEPTIC ULCER; REVIEW; STOMACH CANCER; STRAIN DIFFERENCE;

ADENOCARCINOMA; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; GENE EXPRESSION REGULATION, BACTERIAL; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; PEPTIC ULCER; STOMACH NEOPLASMS; VIRULENCE;

EID: 4344642720     PISSN: 03795284     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (65)

1. McGee DJ, Mobley HLT. Pathogenesis of Helicobacter pylori infection. Curr Opin Gastroenterol 2000; 16: 24-31.
2. Fallone CA, Barkun AN, Gottke MU, Beech RN. A review of the possible bacterial determinants of clinical outcome in Helicobacter pylori infection. Can J Microbiol 1998; 44: 201-210.
3. Rudi J, Kolb C, Maiwald M, Kuck D, Sieg A, Galle PR, Stremmel W. Diversity of Helicobacter pylori VacA and CagA genes and relationship to VacA and CagA protein expression, cytotoxin production and associated diseases. J Clin Microbiol 1998; 36: 944-948.
4. Akopyants NS, Clifton SW, Kersulyte D, Crabtree JE, Youree BE, Reece CA, et al. Analyses of the cag pathogenicity island of Helicobacter pylori. Mol Microbiol 1998; 28: 37-53.
5. Yamaoka Y, Kodama T, Kashima K, Graham DY, Sepulveda AR. Variants of the 3′ region of the CagA gene in Helicobacter pylori isolates from patients with different H. pylori-associated diseases. J Clin Microbiol 1998; 36: 2258-2263.
6. Audibert C, Burucoa C, Janvier B, Fauchere JL. Implication of the structure of the Helicobacter pylori cag pathogenicity island in induction of interleukin-8 secretion. Infect Immun 2001; 69: 1625-1629.
7. Tomasini ML, Zanussi S, Sozzi M, Tedeschi R, Basaglia G, De Paoli P. Heterogeneity of cag genotypes in Helicobacter pylori isolates from human biopsy specimens. J Clin Microbiol 2003; 41: 976-980.
8. Jenks PJ, Mégraud F, Labigne A. Clinical outcome after infection with Helicobacter pylori does not appear to be reliably predicted by the presence of any of the genes of the cag pathogenicity island. Gut 1998; 43: 752-758.
9. Maeda S, Yoshida H, Ikenoue T, Ogura K, Kanai F, Kato N, et al. Structure of the cag pathogenicity island in Japanese Helicobacter pylori isolates. Gut 1999; 44: 336-341.
10. Backert S, Ziska E, Brinkmann V, Zimny-Arndt U, Fauconnier A, Jungblut PR, et al. Translocation of the Helicobacter pylori CagA protein in gastric epithelial cells by a type IV secretion apparatus. Cell Microbiol 2000; 2: 155-164.
11. Rota CA, Pereira-Lima JC, Blaya C, Nardi NB. Consensus and variable region PCR analysis of Helicobacter pylori 3′ region of CagA gene in isolates from individuals with or without peptic ulcer. J Clin Microbiol 2000; 39: 606-612.
12. Ito V, Azume T, Ito S, Miyaji H, Hirai M, Yamazaki V, et al. Analysis and typing of the VacA gene from CagA-positive strains of Helicobacter pylori isolated in Japan. J Clin Microbiol 1997; 35: 1710-1714.
13. Han SR, Schreiber HJ, Bhakdi S, Loos M, Maeurer MJ. VacA genotypes and genetic diversity in clinical isolates of Helicobacter pylori. Clin Diag Lab Immunol 1998; 5: 139-145.
14. Papini E, Zoratti M, Cover TL. In search of the Helicobacter pylori VacA mechanism of action. Toxicon 2001; 39: 1757-1767.
15. Atherton JC, Cover TL, Peek RM, Blaser MJ. Subtyping of Helicobacter pylori strains into two groups by polymerase chain reaction amplification of the VacA gene and correlation of these groups with CagA status. Am J Gastroenterol 1994; 89: 1291-1295.
16. Cover TL, Tummuru M, Ping C, Thompson SA, Blaser MJ. Divergence of genetic sequences for the vacuolating cytotoxin among Helicobacter pylori strains. J Biol Chem 1994; 269: 10566-10573.
17. van Doorn LJ, Figueiredo C, Sanna R, Pena S, Midolo P, Neg EKW, et al. Expanding allelic diversity of Helicobacter pylori VacA. J Clin Microbiol 1998; 36: 2597-2603.
18. Strobel S, Bereswill S, Balig P, Allgaier P, Sonntag HG, Kist M. Identification and analysis of a new VacA genotype variant of H. pylori in different patient groups in Germany. J Clin Microbiol 1998; 36: 1285-1289.
19. Atherton JC, Cao P, Peek RM Jr, Tumurru MK, Blaser MJ, Cover TL. Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori: association of specific VacA types with cytotoxin production and peptic ulceration. J Biol Chem 1995; 270: 17771-17777.
20. Innocenti M, Thoreson AC, Ferrero RL, Strömberg E, Bölin I. Eriksson L, et al. Helicobacter pylori-induced activation of human endothelial cells. Infect Immun 2002; 70: 4581-4590.
21. Ikenoue T, Maeda S, Ogura K, Akanuma M, Mitsuno Y, Imai Y, et al. Determination of Helicobacter pylori virulence by simple gene analysis of the cag pathogenicity island. Clin Diag Lab Immunol 2001; 8: 181-186.
22. Selbach M, Moese S, Meyer TF, Backert S. Functional Analysis of the Helicobacter pylori cag pathogenicity island reveals both VirD4-CagA-dependent and VirD4-CagA-independent mechanisms. Infect Immun 2002; 70: 665-671.
23. Ando T, Peek RM, Pride D, Levine SM, Takata T, Lee YC, et al. Polymorphisms of Helicobacter pylori HP0638 reflect geographic origin and correlate with CagA status. J Clin Microbiol 2002; 40: 239-246.
24. Troost E, Hold GL, Smith MG, Chow WH, Rabkin CS, McColl KE, et al. The role of interleukin-1 beta and other potential genetic markers as indicators of gastric cancer risk. Can J Gastroenterol 2003; 17 Suppl B: 8-12.
25. Hansson LE, Nyren O, Hsing AW, Bergstrom R, Josefsson S, Chow WH, et al. The risk of stomach cancer in patients with gastric or duodenal ulcer disease. N Engl J Med 1996; 335: 242-249.
26. El-Omar EM, Carrington M, Chow WH, McColl KE, Bream JH, Young HA, et al. Interleukin-I polymorphisms associated with increased risk of gastric cancer. Nature 2000; 404: 398-402.
27. Navaglia F, Basso D, Piva MG, Brigato L, Stefani A, Dal Bo N, et al. Helicobacter pylori cytotoxic genotype is associated with peptic ulcer and influence serology. Am J Gastroenterol 1998; 93: 227-230.
28. Rudi J, Kuck D, Rudy A, Sieg A, Maiwald M, Stremmel W. Helicobacter pylori VacA genotypes and CagA gene in a series of 383 H. pylori-positive patients. Z Gastroenterol 2000; 38: 559-564.
29. Kidd M, Lastovica AJ, Atherton JC, Louw JA. Heterogeneity in the Helicobacter pylori VacA and CagA genes: association with gastroduodenal disease in South Africa? Gut 1999; 45: 499-502.
30. Faundez G, Troncoso M, Figueroa G. CagA and VacA in strains of Helicobacter pylori from ulcer and non-ulcerative dyspepsia patients. BMC Gastroenterol 2002; 2: 20-23.
31. Wang JC, Wang TH, Wang HJ, Kuo HJ, Wang JT, Wang WC. Genetic analysis of the cytotoxin-associated gene and the vacuolating toxin gene in H. pylori strains isolated from Taiwanese patients. Am J Gastroenterol 1997; 92: 1316-1321.
32. Park SM, Park J, Kim JG, Cho HD, Cho JH, Lee DH, et al. Infection with H. pylori expressing the CagA gene is not associated with an increased risk of developing peptic ulcer disease in Korean patients. Scand J Gastroenterol 1998; 33: 923-927.
33. Smith SI, Kirsch C, Oyedeji KS, Arigbabu AO, Coker AO, Bayerdoffer E, et al. Prevalence of Helicobacter pylori VacA, CagA and iceA genotypes in Nigerian patients with duodenal ulcer disease. J Med Microbiol 2002; 51: 851-854.
34. Hisada M, Lee MG, Hanchard B, Owens M, Song Q, van Doorn LJ, et al. Characteristics of Helicobacter pylori infection in Jamaican adults with gastrointestinal symptoms. J Clin Microbiol 2001; 99: 212-216.
35. Park SM, Hong SI, Jung HY, Yang SK, Kim HR, Min YI, et al. Antigenic diversity and serotypes of Helicobacter pylori associated with peptic ulcer diseases. Korean J Intern Med 1998; 13: 104-109.
36. Kimmel B, Bosserhoff A, Frank R, Gross R, Goebel W, Beier D. Identification of immunodominant antigens from Helicobacter pylori and evaluation of their reactivities with sera from patients with different gastroduodenal pathologies. Infect Immun 2000; 68: 915-920.
37. Ando T, Perez-Perez G, Kusugami K, Ohsuga M, Block K, Blaser MJ. Anti-CagA immunoglobulin G responses correlate with interleukin-8 induction in human gastric mucosal biopsy culture. Clin Diag Lab Immunol 2000; 7: 803-809.
38. Mitchell HM, Hazell SL, Li YY, Hu PJ. Serological response to specific Helicobacter pylori antigens: Antibody against CagA antigen is not predictive of gastric cancer in a developing country. Am J Gastroenterol 1996; 91: 1785-1789.
39. Tee W, Lambert JR, Dwyer B. Cytotoxin production by H. pylori from patients with upper gastrointestinal tract diseases. J Clin Microbiol 1995; 33: 1203-1205.
40. Busolo F, Bertollo G, Bordignon G, Madia D, Camposampiero D. Detection and characterization of Helicobacter pylori from patients with gastroduodenal diseases. Diagn Microbiol Infect Dis 1998; 31: 531-536.
41. Perez-Perez GI, Bhat N, Gaensbauer J, Fraser A, Taylor DN, Kuipers EJ, et al. Country-specific constancy by age in CagA(+) proportion of Helicobacter pylori infection. Int J Cancer 1997; 72: 453-456.
42. Abasiyanik MF, Sander E, Salih BA. Helicobacter pylori anti-CagA antibodies: Prevalence in symptomatic and asymptomatic subjects in Turkey. Can J Gastroenterol 2002; 16: 527-532.
43. Atherton JC, Cao P, Pekk RM, Tummuru MKR, Blaser MJ, Cover TL. Clinical and pathological importance of heterogeneity in VacA, the vacuolating cytotoxin gene of Helicobacter pylori. Gastroenterol 1997; 112: 92-99.
44. Chattopadhyay S, Datta S, Chowdhury A, Chowdhury S, Mukhopadhyay AK, Rajendran K, et al. Virulence genes in Helicobacter pylori strains from West Bengal residents with overt H. pylori-associated disease and healthy volunteers. J Clin Microbiol 2002; 40: 2622-2625.
45. Andreson H, Lõivukene K, Sillakivi T, Maaroos HI, Ustav M, Peetsalu A, et al. Association of CagA and VacA genotypes of Helicobacter pylori with gastric diseases in Estonia. J Clin Microbiol 2002; 40: 298-300.
46. Fernando N, Holton J, Vaira D, DeSilva M, Fernando D. Prevalence of Helicobacter pylori in Sri Lanka as determined by PCR. J Clin Microbiol 2002; 40: 2675-2676.
47. Zambon CF, Navaglia F, Basso D, Rugge M, Plebani M. Helicobacter pylori babA2, CagA, and s1 VacA genes work synergistically in causing intestinal metaplasia. J Clin Pathol 2003; 56: 287-291.
48. Mizushima T, Sugiyama T, Komatsu Y, Ishizuka J, Kato M, Asaka M. Clinical relevance of the babA2 genotype of Helicobacter pylori in Japanese clinical isolates. J Clin Microbiol 2001; 39: 2463-2465.
49. Lai CH, Kuo CH, Chen YC, Chao FY, Poon SK, Chang CS, et al. High prevalence of CagA- and babA2-positive Helicobacter pylori clinical isolates in Taiwan. J Clin Microbiol 2002; 40: 3860-3862.
50. Hohenberger P, Gretschel S. Gastric cancer. Lancet 2003; 362: 305-315.
51. Talley NJ. Gastric adenocarcinoma and Helicobacter pylori infection. J Natl Cancer Inst 1991; 83: 1734.
52. Blaser MJ, Perez-Perez GI, Kleanthous H, Cover TL, Peek RM, Chyou PH, et al. Infection with Helicobacter pylori strains possessing CagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res 1995; 55: 2111-2115.
53. Kuipers EJ. Exploring the link between Helicobacter pylori and gastric cancer. Aliment Pharmacol Ther1999; 13: 3-11.
54. Williams MP, Pounder RE. Helicobacter pylori: from the benign to the malignant. Am J Gastroenterol 1999; 94: S11-S16.
55. Huang JQ, Sridhar S, Chen Y, Hunt RH. Meta-analysis of the relationship between Helicobacter pylori seropositivity and gastric cancer. Gastroenterol 1998; 114: 1169-1179.
56. Enroth H, Kraaz W, Engstrand L, Nyren O, Rohan T. Helicobacter pylori strain types and risk of gastric cancer: A case-control study. Cancer Epidemiol Biomarkers Prev 2000; 9: 981-985.
57. Harris RA, Owens DK, Witherell H, Parsonnet J. Helicobacter pylori and gastric cancer: What are the benefits of screening only for the CagA phenotype of H. pylori? Helicobacter 1999; 4: 69-76.
58. Miehlke S, Kirsch C, Agha-Amiri K, Gunther T, Lehn N, Malfertheiner P, et al. The Helicobacter pylori VacA s1, m1 genotype and CagA is associated with gastric carcinoma in Germany. Int J Cancer 2000; 87: 322-327.
59. Peng H, Ranaldi R, Diss TC, Isaacson PG, Bearzi I, Pan L. High frequency of CagA+ Helicobacter pylori infection in high-grade gastric MALT B-cell lymphomas. J Pathol 1998; 185: 409-412.
60. Wirth HP, Beins MH, Yang M, Tham KT, Blaser MJ. Experimental infection of Mongolian gerbils with Wild-Type and mutant Helicobacter pylori strains. Infect Immun 1998; 66: 1902-1908.
61. Magnusson PKE, Enroth H, Erikson I, Held M, Nyren O, Engstrand L, et al. Gastric cancer and human leukocyte antigen: Distinct DQ alleles are associated with development of gastric cancer and infection by Helicobacter pylori. Cancer Res 2001; 61: 2684-2689.
62. Queiroz DM, Mendes EN, Rocha GA, Oliveira AM, Oliveira CA, Magalhaes PP, et al. CagA-positive Helicobacter pylori and risk for developing gastric carcinoma in Brazil. Int J Cancer 1998; 78: 135-139.
63. Woodward M, Tunstall-Pedoe H, McColl K. Helicobacter pylori infection reduces systemic availability of dietary vitamin C. Eur J Gastroenterol Hepatol 2001; 13: 233-237.
64. Correa P, Fontham ET, Bravo JC, Bravo LE, Ruiz B, Zarama G, et al. Chemoprevention of gastric dysplasia: randomised trial of antioxidant supplements and anti-Helicobacter pylori therapy. J Natl Cancer Inst 2000; 92: 1881-1888.
65. van Doorn NEM, Namavar F, van Doorn LJ, Durrani Z, Kuipers EJ, Vandenbroucke-Grauls CMJE. Analysis of VacA, CagA, and IS605 genotypes and those determined by PCR amplification of DNA between repetitive sequences of Helicobacter pylori strains isolated from patients with non-ulcer dyspepsia or mucosa-associated lymphoid tissue lymphoma. J Clin Microbiol 1999; 37: 2348-2349.